openPR Logo

Press Releases from Renal Denervation (2 total)

Global Renal Denervation Market to grow at a CAGR of 11.82% during 2016-2020

About Renal Denervation Renal denervation is a catheter-based minimally-invasive ablation procedure that helps reduce systolic blood pressure in individuals with drug-resistant hypertension. Systolic blood pressure is the first recorded reading. Diastolic blood pressure measures the pressure in the blood vessels when the heart rests between beats. The renal denervation catheter is introduced through the femoral artery in the upper thigh. The physician then makes several lesions using radiofrequency or ultrasound along

MediPoint: Renal Denervation - Global Analysis And Market Forecasts

Renal denervation catheters are categorized into the following: radiofrequency (RF) catheters, ultrasound catheters, and micro-injection catheters. Growth in the renal denervation market will be driven primarily by a need for a new intervention to treat resistant hypertension. This technology has the potential to revolutionize the cardiac field, providing a minimally invasive solution where none currently exist. The global market for renal denervation devices is dominated by Medtronic, St. Jude Medical, and Boston Scientific. Other

Go To Page:   1 2 3 4 5 6 7 8 9 10